Presentation TCT 2025 TCT 838: Natural History and Outcomes of Early Aortic Valve Replacement versus Conservative Management in Patients with Asymptomatic Severe Aortic Stenosis: A Meta-Analysis Presenter: Justin Huang October 27, 2025
Presentation TCT 2025 Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients? Presenter: Joao L. Cavalcante October 26, 2025
Presentation TCT 2025 Predictors of a Positive Treadmill Stress Test in Patients with Asymptomatic Severe Aortic Stenosis: Insights from the EARLY TAVR Treadmill Registry Presenter: Philippe Genereux October 25, 2025
Presentation NY Valves 2025 Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial Presenter: Allan Schwartz June 25, 2025
Presentation NY Valves 2025 Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients? Lessons From the EVOLVED Trial Presenter: Marc R. Dweck June 25, 2025
Presentation TCT 2024 TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis Presenter: Philippe Genereux October 30, 2024
Presentation TCT 2024 Lessons Learned From Recent Clinical Trials (EARLY TAVR and AVATAR) Presenter: Allan Schwartz October 30, 2024
Presentation TCT 2024 Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED) Presenter: Mark Dweck October 30, 2024
Presentation TCT 2024 Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis Presenter: Mark Dweck October 28, 2024
Presentation TCT 2024 Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial Presenter: Philippe Genereux October 28, 2024
Presentation TCT 2024 Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis Presenter: Mark Dweck October 28, 2024
Presentation TCT 2024 Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial Presenter: Philippe Genereux October 28, 2024
Presentation TCT 2024 TCT 92: Early Transcatheter or Surgical Aortic Valve Replacement Versus Conservative Management in Asymptomatic Patients With Severe Aortic Stenosis: A Systematic Review and Meta-analysis Presenter: Avinash Nankani October 27, 2024
Presentation NY Valves 2024 Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials Presenter: Nicolas M. Van Mieghem June 06, 2024
Presentation TCT 2023 TCT 775: A Machine Learning Based Model Predicts Death in Patients with Severe Asymptomatic Aortic Stenosis Presenter: APURVA BHARUCHA October 26, 2023
Presentation TCT 2023 TCT 331: Cardiac Damage Staging Predicts Outcomes in Symptomatic and Asymptomatic Aortic Valve Stenosis after Aortic Valve Replacement: Meta-Analysis of Reconstructed Time-to-Event Data Presenter: Omar Abdelfattah October 26, 2023
Presentation TCT 2022 Case Presentation: A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis Presenter: Tom Cahill September 18, 2022
Presentation TCT 2020 TAVR in Low Surgical Risk Patients - Intervention (Surgery or TAVR) in Severe Asymptomatic Aortic Stenosis: Evidence Updates Presenter: Philippe Genereux October 16, 2020
Presentation Live Valves 2019 Asymptomatic AS Live Valves-2019 Presenter: Maurice E. Sarano December 10, 2019
Presentation Outcomes of Patients with Asymptomatic Aortic Stenosis (AS) Followed Up in Heart Valve Clinics October 03, 2018